Recovery of diminished mealtime-associated anticipatory behavior by aniracetam in aged rats

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 4, 2000, Pages 827-833

  Tanaka, Yushiro ^a   Kurasawa, Mitsue ^a   Nakamura, Kazuo ^a  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

Activities of daily living; Aged rats; Aniracetam; Cholinergic system; Mealtime associated anticipation; Temporal regulation of behavior

Indexed keywords

ANIRACETAM; PHYSOSTIGMINE;

AGED; ANIMAL EXPERIMENT; ANTICIPATION; ARTICLE; BEHAVIOR; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEEDING BEHAVIOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

AGING; ANIMALS; CIRCADIAN RHYTHM; DARKNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDING BEHAVIOR; LIGHT; MALE; MOTOR ACTIVITY; NOOTROPIC AGENTS; PARASYMPATHOMIMETICS; PHYSOSTIGMINE; PYRROLIDINONES; RATS; RATS, WISTAR;

EID: 0033872043     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00288-4     Document Type: Article

References (36)

1. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-414.
2. Clarke J.D., Coleman G.J. Persistent meal-associated rhythms in SCN-lesioned rats. Physiol. Behav. 36:1986;105-113.
3. Ghiani C.A., Dazzi L., Maciocco E., Flore G., Maira G., Biggio G. Antagonism by abecarnil of enhanced acetylcholine release in the rat brain during anticipation but not consumption of food. Pharmacol. Biochem. Behav. 59:1998;657-662.
4. Gottfries C.G., Blennow K., Karlsson I., Wallin A. The neurochemistry of vascular dementia. Dementia. 5:1994;163-167.
5. Himori N., Mishima K. Amelioration by aniracetam of abnormalities as revealed in choice reaction performance and shuttle behavior. Pharmacol. Biochem. Behav. 47:1994;219-225.
6. Honma H., Takei A., Fukazawa T., Hamada K., Hamada T., Tashiro K. Treatment of Parkinson's disease with aniracetam. Aging Dis. 8:1995;96-99.
7. Hutter B.O., Gilsbach J.M., Kreitschmann I. Quality of life and cognitive deficits after subarachnoid haemorrhage. Br. J. Neurosurg. 9:1995;465-475.
8. Inglis F.M., Day J.C., Fibiger H.C. Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal. Neuroscience. 62:1994;1049-1056.
9. Katayama T. Spontaneity in dementia. An analysis of 696 institutionalized elderly patients Keio J. Med. 47:1998;85-91.
10. Katsunuma H., Shimizu T., Ogawa K., Kubo H., Ishida H., Yoshihama A. Treatment of insomnia by concomitant therapy with zopiclone and aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease. Psychiatr. Clin. Neurosci. 52:1998;198-200.
11. Lolova I.S., Lolov S.R., Itzev D.E. Changes in NADPH-diaphorase neurons of the laterodorsal and pedunculopontine tegmental nuclei in aging. Mech. Aging Dev. 90:1996;111-128.
12. Martin J.R., Haefely W.E. Pharmacology of Aniracetam. A novel pyrrolidinone derivative with cognition enhancing activity Drug Invest. 5(Suppl. 1):1993;4-49.
13. Mishima K., Hishikawa Y. Chronotherapy for circadian rhythm disorders in elderly patients with dementia. Hayaishi O., Inoué S. Sleep and sleep disorders. From molecule to behavior:1997;177-191 Academic Press, Tokyo.
14. Mistlberger R.E., Houpt T.A., Moore-Ede M.C. Effects of aging on food-entrained circadian rhythms in the rat. Neurobiol. Aging. 11:1990;619-624.
15. Mistlberger R.E. Circadian food-anticipatory activity. Formal models and physiological mechanisms Neurosci. Biobehav. Rev. 18:1994;171-195.
16. Mitsushima D., Mizuno T., Kimura F. Age-related changes in diurnal acetylcholine release in the prefrontal cortex of male rats as measured by microdialysis. Neuroscience. 72:1996;429-434.
17. Nabeshima T. Ameliorating effects of nefiracetam (DM-9384) on brain dysfunction. Drugs Today. 30:1994;357-379.
18. Nakamura K., Kurasawa M., Tanaka Y. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam. Drug Dev. Res. 43:1998;85-97.
19. Nakamura K., Kurasawa M., Tanaka Y. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. Eur. J. Pharmacol. 342:1998;127-138.
20. Nakamura K., Shirane M. Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam. Eur. J. Pharmacol. 380:1999;81-89.
21. Ono M., Minamoto Y., Shibata S., Watanabe S. Attenuating effect of arecoline and physostigmine on an impairment of mealtime-associated activity rhythm in old rats. Physiol. Behav. 57:1995;189-191.
22. Ono M., Shibata S., Minamoto Y., Watanabe S. Effect of the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 on food-anticipatory activity rhythm in the rat. Physiol. Behav. 59:1996;585-589.
23. Otomo E., Hirai S., Terashi A., Hasegawa K., Tazaki Y., Araki G., Ito E., Nishimura T., Furukawa T. Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders. Double-blind trial in placebo J. Clin. Exp. Med. 156:1991;143-187.
24. Perry E.K., Perry R.H. Acetylcholine and hallucinations; disease-related compared to drug-induced alternations in human consciousness. Brain Cognit. 28:1995;240-258.
25. Raza A., Milbrandt J.C., Arneric S.P., Caspary D.M. Age-related changes in brainstem auditory neurotransmitters. Measures of GABA and acetylcholine function Hear. Res. 77:1994;221-230.
26. Robbins T.W., McAlonan G., Muir J.L., Everitt B.J. Cognitive enhancers in theory and practice. Studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease Behav. Brain Res. 83:1997;15-23.
27. Sakurada T., Alufuzoff I., Winblad B., Nordberg A. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Res. 521:1990;329-332.
28. Schubert D.S., Taylor C., Lee S., Mentari A., Tamaklo W. Physical consequences of depression in the stroke patient. Gen. Hosp. Psychiatry. 14:1992;69-76.
29. Schut L.J. Dementia following stroke. Clin. Geriatr. Med. 4:1988;767-784.
30. Shibata S., Minamoto Y., Ono M., Watababe S. Age-related impairment of food anticipatory locomotor activity in rats. Physiol. Behav. 55:1994;875-878.
31. Shirane M., Nakamura K. Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S, 3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP. Neuropharmacology. 39:2000;866-872.
32. Stephan F.K. Interaction between light- and feeding-entrainable circadian rhythms in the rat. Physiol. Behav. 38:1986;127-133.
33. 2 receptor-mediated head-twitch response in rodents as a hallucination model. Drug Dev. Res. 44:1998;131-139.
34. Tohgi H., Abe T., Kimura M., Saheki M., Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J. Neural. Transm. 103:1996;1211-1220.
35. Witting W., Kwa I.H., Eikelenboom P., Mirmiran M., Swaab D.F. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol. Psychiatry. 27:1990;563-572.
36. Witting W., Mirmiran M., Bos N.P.A., Swaab D.F. The effect of old age on the free-running period of circadian rhythms in rat. Chronobiol. Int. 11:1994;103-112.